ARX 0.79% 62.5¢ aroa biosurgery limited

Come on finish $5 plus, page-58

  1. 244 Posts.
    lightbulb Created with Sketch. 35
    In retrospect that was a great idea. I wish I had done the same. And what's more there have been plenty of opportunities to buy back in at the current level. I have held these since IPO but have been a little disappointed with the way the share price has been tracking.
    In terms of companies performance, caliber of management, revenue growth, product IP, product pipeline development, and general strategy, I couldn't be happier. If ARX continues to meet their revenue and profitability targets, it is just a matter of time before the company get re-rated. I would be interested in your views when they release their full year numbers.
    Thanks for your reply.



 
watchlist Created with Sketch. Add ARX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.